Covidien Launches Nationwide Type 2 Diabetes Campaign

Covidien, a leading global healthcare products company, has announced the launch of the Our Resolution movement, a collaborative effort between healthcare experts, nonprofit organizations, health agencies, patients, and spokespersons who share the goal of resolving Type 2 diabetes. The movement is focused...

In3 East: June 23-25, 2009 at the Westin Copley Boston

Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker Instruments, Wright Medical Technology, Integra LifeSciences, and more are sending their teams to...

Clarient Launches New Gene Mutation Test for Lung Cancer

Clarient, a provider of comprehensive anatomic pathology and molecular testing services, has launched a new gene mutation test to help physicians select the appropriate therapy for non-small cell lung cancer (NSCLC), the most common form of lung cancer. The test, called epidermal growth factor receptor...

Frontrunners Emerge In Swine Flu Vaccine Race

Just days after the World Health Organization declared a swine flu pandemic, Fierce Biotech reports that two pharmaceutical companies are already racing to complete clinical trials of their H1N1 vaccines. Chinese company Sinovac Biotechnology says it can complete a clinical trial by the end of July, while...

TearLab Wins Silver Medical Design Excellence Award

TearLab Corporation of San Diego announced that its TearLab Osmolarity System has received a Silver 2009 Medical Design Excellence Award (MDEA). MDEA is the premier awards program for the medical technology community, recognizing top innovations in medical device manufacturing. Winners received their...

Positive Results for Human Genome’s Lupus Drug Benlysta

Biotechnology company Human Genome Sciences reported that its drug candidate Benlysta reduced symptoms of lupus in a long-term clinical trial. The four-year Phase II study showed that Benlysta (also known as belimumab) decreased the severity and frequency of flare-ups in patients with a form of the...

Less Than Two Weeks Until IN3 East

Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker Instruments, Wright Medical Technology, Integra LifeSciences, and more have already decided to...

NeuroSearch’s Tesofensine Advances to Phase III Testing

Yesterday, OneMedPlace reported on several companies that are developing anti-obesity drugs. Another name can be added to the list: NeuroSearch of Denmark is preparing to advance their experimental weight loss drug, tesofensine, to the final stage of clinical testing. On Monday, the company announced that...